Brief: Briacell Therapeutics Granted New Zealand Patent For Whole-Cell Cancer Vaccines
30/07/2025 12:57
July 30 (Reuters) - Briacell Therapeutics Corp BCT.TO: BRIACELL THERAPEUTICS CORP - GRANTED NEW ZEALAND PATENT FOR WHOLE-CELL CANCER VACCINES BRIACELL THERAPEUTICS CORP - PATENT PROVIDES EXCLUSIVITY THROUGH 2037 FOR PRECISION MEDICINE Source text: ID:nGNXwGfxW Further company coverage: BCT.TO ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Briacell Therapeutics
See all newsBrief: Briacell Therapeutics Prices 1.45 Million Common Shares At $3.25 Per Share
Brief: Briacell Receives Positive Recommendation From Data Safety Monitoring Board (Dsmb) For Phase 3 Study In Metastatic Breast Cancer
Brief: Briacell Expands Pipeline To Include An Ovarian Cancer Immunotherapy Candidate, Bria-Ova+™
Brief: Briacell Phase 3 Bria-Imt™ Study Enrollment Surpasses 230 Patients
Brief: Briacell Adds Nyu Langone Health’S Perlmutter Cancer Center As Clinical Site In Pivotal Phase 3 Breast Cancer Study